- Home
- AVIR vs ITIC Comparison
AVIR vs ITIC Comparison
Compare AVIR & ITIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AVIR | ITIC |
|---|---|---|
| Founded | 2012 | 1972 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Specialty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 450.9M | 431.1M |
| IPO Year | 2020 | 1995 |
Fundamental Metrics
Financial Performance| Metric | AVIR | ITIC |
|---|---|---|
| Price | $5.76 | $218.76 |
| Analyst Decision | Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $8.00 | N/A |
| AVG Volume (30 Days) | ★ 577.0K | 10.9K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 4.83% |
| EPS Growth | 3.00 | ★ 13.02 |
| EPS | N/A | ★ 18.57 |
| Revenue | ★ $351,367,000.00 | $272,755,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.78 |
| Revenue Growth | N/A | ★ 5.60 |
| 52 Week Low | $2.46 | $190.20 |
| 52 Week High | $6.45 | $288.98 |
Technical Indicators
Market Signals| Indicator | AVIR | ITIC |
|---|---|---|
| Relative Strength Index (RSI) | 59.48 | 43.34 |
| Support Level | $3.33 | $209.72 |
| Resistance Level | $6.45 | $221.39 |
| Average True Range (ATR) | 0.28 | 6.18 |
| MACD | -0.07 | 1.33 |
| Stochastic Oscillator | 63.36 | 40.49 |
Price Performance
Historical ComparisonAbout AVIR Atea Pharmaceuticals Inc.
Atea Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of oral antiviral therapies for serious viral diseases. The company's pipeline includes a regimen of bemnifosbuvir and ruzasvir for the treatment of hepatitis C virus (HCV) infection and AT-587 for the treatment of hepatitis E virus (HEV) infection.
About ITIC Investors Title Company
Investors Title Co operates in the title insurance and exchange services sectors. The title insurance segment, conducted through ITIC and NITIC, offers title insurance policies for residential, commercial, and industrial properties in around 22 states and the District of Columbia, with a focus on the eastern United States. The title insurance segment issues title insurance policies through approved attorneys from underwriting offices and through independent issuing agents. Title insurance policies insure titles to real estate.n The Title Insurance segment contributes the majority of the company's revenue.